| Trial ID: | L1791 |
| Source ID: | NCT00121966
|
| Associated Drug: |
Insulin Aspart
|
| Title: |
South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus
|
| Acronym: |
SDDS
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Insulin Aspart|DRUG: Insulin NPH|DRUG: Metformin|DRUG: Rosiglitazone
|
| Outcome Measures: |
Primary: HbA1c following two years of treatment | Secondary: body weight|blood pressure|fasting blood glucose|diurnal blood glucose profiles (self monitored and continuously monitored)|fasting cholesterol (including HDL, LDL, and triglyceride)|free fatty acids|lactate|fasting insulin, proinsulin-C-peptide|urine glucose|urine albumin/creatinine ratio
|
| Sponsor/Collaborators: |
Sponsor: Odense University Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
400
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2003-01
|
| Completion Date: |
2007-07
|
| Results First Posted: |
|
| Last Update Posted: |
2008-06-19
|
| Locations: |
Diabetes Research Center, Odense, 5000, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00121966
|
